MD Anderson Cord Blood BankMarch 24, 2022

FDA 483 - MD Anderson Cord Blood Bank - March 24, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of MD Anderson Cord Blood Bank in Houston, TX, identified a significant quality system deficiency. The firm lacked written procedures for reprocessing cord blood batches, specifically for a particular machine, despite having reprocessed a unit due to low cell recovery.

Company: MD Anderson Cord Blood Bank
Inspection Date: March 24, 2022
Product Type: Biologics
Office: Division of Human and Animal Food Operations - West III
People: Lauren M. Lilly (Compliance Officer at FDA)
Darla J. Christopher (Investigator)

Open in Dashboard

ID · db3527e9-212a-4b43-9ddf-f02d0dafd663